% Expired Patents = 75.0

Forward Citations = 11

Loading Chart...

7 inventors (with patents filed for the assignee):

M David Weingarten (3 out of 9 patents)

Wei Zhang (1 out of 2 patents)

Raymond A Ng (1 out of 5 patents)

4. Robert A D Scott (1 out of 1 patent)

5. Christopher M Chappelow (1 out of 2 patents)

6. Charles Q Meng (1 out of 15 patents)

7. James A Sikorski (1 out of 130 patents)

4 patents: Sort by Forward Citations

1. 8252840 - Methods of derivatives of probucol for the treatment of type II diabetes (2012-08-28),

2. 7897776 - Sulfonamide containing compounds for treatment of inflammatory disorders (2011-03-01),

3. 7687659 - Process for the separation of probucol derivatives (2010-03-30),

4. 7622604 - Process of preparing esters and ethers of probucol and derivatives thereof (2009-11-24),

Company Overview

Salutria Pharmaceuticals LLC is a research-driven biopharmaceutical company dedicated to developing innovative therapies to improve the lives of patients. Our mission is to advance groundbreaking treatments in areas of high unmet medical need, with a focus on oncology and rare diseases. Through strategic partnerships and collaborations, we are committed to delivering innovative solutions that address the evolving healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#101 in Alpharetta, GA

#1,160 in Georgia

#60,641 in US

Alpharetta, GA, United States of America

Salutria Pharmaceuticals LLC

Forward Citations = 11

7 inventors:

M David Weingarten (3 out of 9 patents)

Wei Zhang (1 out of 2 patents)

Raymond A Ng (1 out of 5 patents)

4. Robert A D Scott (1 out of 1 patent)

5. Christopher M Chappelow (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Salutria Pharmaceuticals LLC. Retrieved from https://idiyas.com/company/salutria-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]